IP Verse

Compositions And Methods Of Formulation For Enteral Formulas Containing Sialic Acid - EP1811868

EP1811868

BRISTOL MYERS SQUIBB
Application Number
EP05801808A
Filing Date
Sep 30, 2005
Status
Revoked
Jan 21, 2022
Grant Date
Aug 15, 2018
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3781132B1
EP3818078B1
EP3631454B1

Bibliography

The patent EP1811868B1 was granted to Bristol Myers Squibb on Aug 15, 2018 following the initial filing on Sep 30, 2005 under the application number EP05801808A . The current legal status of the patent is Revoked.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

NUTRICIAMay 15, 2019ADMISSIBLE
ABBOTTMay 9, 2019ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents